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CDObjective: Previous studies on outcome of cardiac surgery and its predictors in pa-
tients with preoperative kidney failure requiring dialysis have included small numbers
of patients with limited follow-up. In addition, predictors of long-term outcome are
not well characterized.
Methods: This is a retrospective analysis of prospectively collected data for 6694 pa-
tients, including 245 (3.7%) patients with end-stage kidney failure requiring dialysis
who underwent cardiac surgery between January 1998 and September 2006. Potential
predictors of hospital mortality, complications, and late survival were retrospectively
analyzed by using multivariate regression models.
Results: Patients with end-stage kidney failure requiring dialysis had a 3.9-times
higher hospital mortality rate compared with other cardiac surgery patients (12.7%
vs 3.6%, P , .001). Patients with end-stage kidney failure requiring dialysis were
younger but presented with more comorbidities and more severe cardiac disease
than the control group. After adjusting for potential confounding factors, end-stage
kidney failure requiring dialysis was identified as a predictor of hospital mortality
(odds ratio, 3.1; P , .001). Patients with end-stage kidney failure requiring dialysis
also had an increased risk of postoperative sepsis (odds ratio, 2.7; P , .001) and re-
spiratory failure (odds ratio, 2.0; P, .001). Peripheral vascular disease was an inde-
pendent predictor of hospital mortality in patients with end-stage kidney failure
requiring dialysis (odds ratio, 2.5; P 5 .001). Long-term survival was significantly
decreased in patients with end-stage kidney failure requiring dialysis compared
with that seen in the control group (1-year and 5-year survival: 72.3% 6 3.3% and
39.0%6 4.5% vs 94.2%6 0.3% and 83.2%6 0.6%, P, .001). Peripheral vascular
disease (odds ratio, 2.69; P 5 .008) and previous stroke (odds ratio, 4.37; P , .001)
were independent risk factors of late mortality in the subgroup of patients with end-
stage kidney failure requiring dialysis.
Conclusions: Preoperative renal failure requiring dialysis is associated with a signifi-
cant increase in hospital mortality, postoperative sepsis, and respiratory failure in pa-
tients undergoing cardiac surgery. In these patients long-term survival is particularly
reduced in the presence of advanced atherosclerotic disease.
E
nd-stage kidney failure requiring dialysis (ESRD) represents a major public
health problem in the United States related to an aging population and an
increasing incidence of certain risk factors, such as diabetes mellitus, hyper-
tension, and atherosclerotic disease.1 Patients with ESRD are at higher risk for the de-
velopment of cardiovascular diseases, including coronary artery disease and valvular
heart disease.2 An improved survival of patients with ESRD in recent years has led to
an increased referral of dialysis patients for cardiac surgery. The postoperative out-
comes after cardiac surgery are worse compared with those of patients without
ESRD.3 However, most previous studies are limited by small sample size and unable
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CPB 5 cardiopulmonary bypass
ESRD 5 end-stage kidney failure requiring dialysis
OR 5 odds ratio
PVD 5 peripheral vascular disease
to identify independent predictors of outcome. In addition,
they have primarily focused on early surgical results with
limited follow-up. In this study we report our clinical experi-
ence in a large contemporary series of patients with ESRD
who underwent cardiac surgery at a single institution. We
sought to determine surgical outcomes and predictors of early
and late mortality.
Materials and Methods
We retrospectively analyzed a series of 6940 consecutive patients
undergoing cardiovascular surgery at the Mount Sinai Medical Cen-
ter between January 1998 and September 2006. Patients undergoing
cardiac transplantation and ventricular assist device implantation
(n 5 246) were excluded from this study. The remaining 6694
patients were included in the statistical analysis. Two hundred
forty-five patients with ESRD constituted the study group, whereas
6449 patients served as the control group. Patients were further
divided into 4 groups according to the surgical procedure (isolated
valve procedures, n5 1454 [22%]; coronary artery bypass grafting
[CABG], n 5 2916 [43%]; combined valve/CABG procedures,
n5 1071 [16%]; and aortic procedures, n5 1253 [19%]). The pro-
tocol was approved by the institutional review board and complies
with the Health Insurance Portability and Accountability Act and
the ethical guidelines of the 1975 declaration of Helsinki, as
revised in 2000.The approval included awaiver of informed consent.
Data Collection
Clinical variables were prospectively entered into the New York
State Department of Health (State Cardiac Advisory Committee)
data registry. The New York State Department of Health data regis-
try represents a mandatory, verified, peer-reviewed data collection
system including all adult cardiac surgery procedures in the state
of New York and records and analyzes data in a strictly supervised
and widely reported fashion.4 Patient demographics and risk factors,
operative information, and postoperative outcome data were retro-
spectively analyzed. Additional information was obtained from pa-
tient charts when necessary. Appendix 1 shows preoperative
variables and their definitions. In addition, the logistic EuroSCORE
was used for risk stratification.5 The EuroSCORE is a risk-stratifica-
tion system using multiple preoperative risk factors to predict oper-
ative mortality. Patients were stratified according to EuroSCORE as
follows: EuroSCORE of 9% or less, low to moderate risk; Euro-
SCORE of greater than 9% to 25%, high risk; and EuroSCORE of
greater than 25%, very high risk.5 Outcome measures in this study
included hospital mortality, major postoperative complications,
and length of stay in the hospital (Appendix 1). Follow-up survival916 The Journal of Thoracic and Cardiovascular Surgery c Apinformation was obtained by cross-matching the patient’s social
security number with the Web-based social security death index.
Operative Procedures and Perioperative
Management
Hemodialysis was performed in all patients in the ESRD group 12 to
24 hours before surgical intervention. All procedures were per-
formed by using standard anesthetic and surgical techniques.
A small skin incision and a full or partial sternotomy were per-
formed in patients undergoing valve, CABG, or aortic surgery pro-
cedures involving the ascending aorta or the aortic arch. Descending
thoracic aortic surgery was performed through a left thoracotomy
approach. After systemic heparinization, cardiopulmonary bypass
(CPB) was instituted between the ascending aorta and either the
right atrium by using a 2-stage cannula or both venae cavae. During
CPB, a minimum flow of 2.5 L $ min21 $ m22 and mean arterial
pressures of approximately 60 mm Hg (70 mm Hg in patients
with peripheral vascular disease [PVD]) were maintained. Cardio-
plegia with high-potassium cold blood was administered in an ante-
grade fashion, a retrograde fashion, or both for myocardial
protection. In patients undergoing valve surgery, further myocardial
protection was obtained with mild-to-moderate systemic cooling
(28C–30C). Procedures involving the aortic arch were performed
during deep hypothermic circulatory arrest. After the completion of
CPB, protamine was administered based on the heparin level. Intra-
operative variables used in this study are reported in Appendix 1. Pa-
tients with ESRD underwent postoperative hemodialysis routinely
on the second day after surgical intervention or earlier if volume
overload or hyperkalemia was present.
Statistical Analysis
Normally distributed continuous variables are presented as means6
standard deviations and otherwise as medians and interquartile
ranges. Categorical variables are shown as the percentage of the
sample. The c2 test was used to evaluate potential confounders of
the relationship between ESRD and hospital mortality and morbid-
ities in the entire patient population. Stepwise multivariate logistic
regression was then performed to assess the influence of ESRD as
an independent risk factor for hospital mortality and postoperative
morbidities.6 The potential confounders included age, sex, obesity
(body mass index .30 kg/m2), ejection fraction, congestive heart
failure, previous cardiac procedure, history of diabetes mellitus,
hypertension, history of myocardial infarction, acute myocardial
infarction, chronic obstructive pulmonary disease, PVD, hemo-
dynamic instability, and type of operative procedure (isolated
CABG, valvular surgery, combined valve/CABG, and aortic proce-
dures). Long-term survival was analyzed by using Kaplan–Meier
survival curves. Differences in patient characteristics were con-
trolled with Cox proportional hazard analysis. The statistical analy-
ses were performed with SPSS 15 (SPSS, Inc, Chicago, Ill).
Results
Demographic Data
A total of 6694 patients were included in this study. Hemodi-
alysis-dependent renal failure was present in 245 (3.7%) pa-
tients. During the study period, the prevalence of patients
with ESRD increased (3.0% in 1998 to 5.1% in 2006, P 5
.008). There were important differences in preoperativeril 2008
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(Table 1). Patients with ESRD were younger (P , .001)
and were more likely to present with hypertension (P 5
.001), diabetes mellitus (P , .001), PVD (P , .001), prior
cerebrovascular accident (P, .001), congestive heart failure
(P, .001), and an ejection fraction of 30% or less (P, .001)
when compared with the control group. These patients also
presented significantly more often with acute endocarditis
(P , .001) and hemodynamic instability on admission
(P, .001). The mean predicted mortality by means of Euro-
SCOREwas significantly higher in the study group (18.5%6
17.5%) compared with that seen in the control group (11.6%
6 13.3%, P, .001). Finally, patients with ESRD were more
likely to undergo isolated single or multiple valve procedures
(P 5 .001) and less likely to undergo aortic procedures
(P 5 .017) compared with the control population. The most
common valve operation in patients with ESRD was aortic
valve replacement, followed by mitral valve procedures.
Hospital Mortality
The overall hospital mortality was 3.9% (262 patients). In pa-
tients with ESRD, univariate analysis showed a significantly
increased hospital mortality (n5 31 [12.7%]) compared with
that seen in the control group (n 5 231 [3.6%], P , .001,
Table 2). When patients were stratified by EuroSCORE,
the observed mortality rate was higher for patients with
ESRD in all 3 predicted risk groups compared with the con-
trol group (P , .001, Figure 1). When patients with ESRD
were stratified by procedure, it appeared that the highest mor-
tality rate occurred in patients undergoing single/multiple
valve procedures (17.1%), followed by combined valve/
CABG (12.8%), isolated CABG (10.3%), and aortic (9.1%)
procedures (Figure 2).
The estimated odds of ESRD hospital mortality, relative to
the control group, was 3.9 (95% confidence interval [CI],
2.6–5.8; P , .001)). In a stepwise, multivariate, logistic
regression analysis including the entire patient population,
ESRD remained a statistically significant independent factor
predicting the risk of hospital mortality (relative odds ratio
[OR], 3.1; 95% CI, 2.0–5.0; P, .001). Multivariate analysis
also revealed hemodynamic instability (OR, 4.1; 95% CI,
2.6–6.4; P , .001), acute myocardial infarction (OR, 5.0;
95% CI, 2.5–10.1; P , .001), PVD (OR, 2.8; 95% CI,
2.1–3.9; P , .001), reoperation (OR, 1.7; 95% CI, 1.3–2.4;
P 5 .001), endocarditis (OR, 2.5; 95% CI, 1.4–4.4;
P 5 .002), ejection fraction of 30% or less (OR, 1.8; 95%
CI, 1.2–2.6; P 5 .002), age greater than 70 years (OR, 1.4;
95% CI, 1.1–1.9; P 5 .013), female sex (OR, 1.4; 95% CI,
1.1–1.8; P 5 .019), congestive heart failure (OR, 1.6; 95%
CI, 1.2–2.2; P 5 .002), and an operation involving the
thoracic aorta (OR, 2.0; 95% CI, 1.4–2.8; P , .001) as
independent predictors of hospital mortality. Because of
the relatively large sample size, we also performed a secondThe Journal of Thoanalysis of independent predictors of hospital mortality in
patients with ESRD. This analysis revealed only PVD as an
independent predictor of hospital mortality (OR, 2.5; 95%
CI, 1.1–5.7; P 5 .001).
Morbidity
In univariate analysis patients with ESRD presented signifi-
cantly more often with respiratory failure (P , .001), sepsis
(P , .001), and gastrointestinal complications (P , .001)
compared with the control group. Variables associated with
postoperative morbidities in univariate analysis were intro-
duced into stepwise logistic regression analysis. In this mul-
tivariate analysis the correlation between ESRD and the
occurrence of respiratory failure and sepsis remained statisti-
cally significant. However, the correlation between dialysis-
dependent renal failure and gastrointestinal complications
disappeared (Table 3). The mean length of stay in the hospital
TABLE 1. Patient demographic and risk factors
Characteristic
Control group
(n 5 6449)
Dialysis group
(n 5 245) P value
Female sex 2423 (37.6%) 91 (37.1%) .475
Age (year) 63.9 6 13.8 61 6 13.2 .000
Age .70 y 2327 (36.1%) 62 (25.3%) .001
Body mass
index (kg/m2)
26.8 6 6.2 26.4 6 5.3 .605
Body mass
index .30 kg/m2
1395 (21.6%) 48 (19.6%) .250
Ejection fraction (%) 47.6 6 14.2 43.8 6 14.9 .000
Ejection fraction ,30% 719 (11.1%) 40 (16.3%) .010
Hypertension 3016 (46.8%) 140 (57.1%) .001
Diabetes 1548 (24.0%) 104 (42.4%) .000
Peripheral vascular
disease
776 (12.0%) 66 (26.9%) .000
Cerebrovascular accident 490 (7.6%) 38 (15.5%) .000
Chronic obstructive
pulmonary disease
462 (7.2%) 14 (5.7%) .234
Prior myocardial infarction 1938 (30.1%) 81 (33.1%) .174
Acute myocardial
infarction
77 (1.2%) 4 (1.6%) .345
Congestive heart failure 1888 (29.3%) 129 (52.7%) .000
Hemodynamic instability 193 (3.0%) 22 (9.0%) .000
Reoperation 958 (14.9%) 36 (14.7%) .517
Endocarditis 128 (2.0%) 28 (11.4%) .000
EuroSCORE 11.6% 6 13.3% 18.0% 6 17.5% .000
Low-moderate risk (,9%) 3762 (58.3%) 59 (24.1%) .000
High risk (9%–25%) 1720 (26.7%) 93 (38.0%) .000
Very high risk (.25%) 967 (15.0%) 93 (38.0%) .000
Procedures
Isolated valve procedures 1378 (21.4%) 76 (31.0%) .001
Isolated CABG procedures 2819 (43.7%) 97 (39.6%) .113
Combined valve/CABG and
other procedures
1032 (16.0%) 39 (15.9%) .529
Aortic procedures 1220 (18.9%) 33 (13.5%) .017
CABG, Coronary artery bypass grafting.racic and Cardiovascular Surgery c Volume 135, Number 4 917
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of stay among patients with ESRD was 25 6 34 days com-
pared with 12 6 17 days in the control group (P , .001).
Late Survival
Follow-up survival information was available for 98% (n 5
6304/6432) of discharged patients. Among 214 surviving pa-
tients with ESRD, follow-up information was available for
212 patients. The overall mean follow-up was 3.9 6 2.5
years, with 3.16 2.4 years for patients with ESRD compared
with 3.9 6 2.5 years for control subjects (P , .001). There
were 973 (15.1%) deaths during the total follow-up period
of 22,697 patient-years. During follow-up, 94 (44%) patients
died in the ESRD group compared with 879 (14.1%) deaths
in the control group (P , .001). Multivariate analysis re-
vealed ESRD (OR, 5.6; 95% CI, 4.0–7.9; P , .001) as an
independent predictor of late mortality after cardiac surgery
TABLE 2. Mortality and Morbidity
Complication
Control group
(n 5 6449)
Dialysis group
(n 5 245) P value
In-hospital mortality 231 (3.6%) 31 (12.7%) .000
Renal failure 139 (2.2%) —
Respiratory failure 617 (9.6%) 53 (21.6%) .000
Sepsis 188 (2.9%) 27 (11.0%) .000
Gastrointestinal complications 101 (1.6%) 10 (4.1%) .000
Cerebrovascular accident 160 (2.5%) 8 (3.3%) .273
Sternal infection 103 (1.6%) 6 (2.4%) .209
Myocardial infarction 39 (0.6%) 2 (0.8%) .446
Reoperation for bleeding 158 (2.4%) 4 (1.6%) .286
LOS $7 d 3775 (58.5%) 189 (77.1%) .000
LOS, Length of stay in hospital.
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Figure 1. Crude mortality according to EuroSCORE group. ESDR,
End-stage renal failure requiring dialysis.918 The Journal of Thoracic and Cardiovascular Surgery c Apr(Table 3). Survival at 1 and 5 years was 72.3% 6 3.3%
and 39.0% 6 4.5% in the ESRD group and 94.2% 6 0.3%
and 83.2% 6 0.6% in the control group, respectively (P ,
.001). Figure 3 shows adjusted Kaplan–Meier survival curves
for the entire patient population stratified by study and con-
trol group. In the subgroup of patients with ESRD, PVD
(OR, 2.7; 95% CI, 1.3–5.6; P5 .008) and previous cerebro-
vascular accident (OR, 4.4; 95% CI, 1.8–10.8; P 5 .001)
were independent predictors of late mortality. Three-year sur-
vival of patients with additional stroke or PVD was 14.1%6
7.2% and 32.8% 6 7.8%, respectively. Figure 4 shows the
effect of PVD and previous stroke on long-term survival in
patients with ESRD after cardiac surgery.
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Figure 2. Crude mortality according to procedure. CABG, Coronary
artery bypass grafting, ESDR, end-stage renal failure requiring
dialysis.
TABLE 3. The effect of dialysis of hospital mortality and
morbidity in multivariate analysis
OR 95% CI P value
Death 3.12 1.96–4.97 .000
Sepsis 2.65 1.64–4.28 .000
Respiratory failure 1.96 1.38–2.80 .000
Gastrointestinal
complication
1.64 0.79–3.38 .183
Bleeding 0.62 0.23–1.73 .364
Myocardial infarction 1.22 0.28–5.25 .788
Sternal infection 0.88 0.37–2.12 .783
Stroke 1.07 0.51–2.27 .856
Late death 5.64 4.03–7.88 .000
OR, Odds ratio; 95% CI, 95% confidence interval.il 2008
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Figure 3. Nonadjusted (A) and adjusted (B) survival curves for pa-
tients with and without end-stage renal failure requiring dialysis
(ESDR).
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Figure 4. Impact of peripheral vascular disease (PVD) (A) and ce-
rebrovascular accident (CVA) (B) on long-term survival in dialysis-
dependent patients.A
CDDiscussion
Incidence
The prevalence of chronic renal disease among the popula-
tion of the United States is steadily increasing, with more
than 472,000 patients with end-stage renal failure in 2004,
a number that is expected to double by 2010.7 Cardiovascular
disease is frequently associated with ESRD and is the most
common cause of death in this patient population.8 Liu and
colleagues9 reported a multicenter series including more
than 15,000 patients who underwent isolated CABG between
1992 and 1997 and reported an incidence of 1.8% (n5 279)
patients with ESRD. Ferguson and associates10 analyzed the
Society of Thoracic Surgeons national database entries ofThe Journal of Thorpatients who underwent CABG between 1990 and 1999
and reported an increasing rate of patients with renal failure
(creatinine value of .2 mg/dL or dialysis), from 3.0% in
1990 to 4.6% in 1999. Similarly, in our study we observed
an increase in the prevalence of patients with ESRD during
the study period (3.0% in 1998 and 5.1% in 2006, P 5
.008). The demographic profile of patients with ESRD was
similar to that reported in previous studies.9,11 These patients
represent a challenging population with high comorbidity,
such as peripheral and cerebrovascular diseases, hyperten-
sion, and diabetes. Accordingly, the predicted operative mor-
tality determined by means of EuroSCORE was significantly
higher compared with that in the control group.acic and Cardiovascular Surgery c Volume 135, Number 4 919
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Previous studies have identified ESRD as a major risk factor
for postoperative morbidity and mortality. In 2000 Horst and
coworkers12 published a review of the literature including 20
studies with a total of 863 dialysis-dependent patients who
underwent all types of cardiac procedures. In this review
the overall operative mortality was 12.5%. In their multicen-
ter study among patients undergoing CABG from northern
New England, Liu and colleagues9 reported a 3-times higher
adjusted mortality rate in dialysis-dependent patients (9.6%)
compared with those with normal renal function (3.1%). Our
experience confirmed these findings: the adjusted risk of hos-
pital mortality was more than 3-times higher in patients with
ESRD. Hospital mortality rate was increased regardless of
the underlying procedure. The highest mortality rate, how-
ever, was observed in patients undergoing valvular surgery
and combined valve/CABG procedures. This finding sup-
ports 2 small previous studies that focused primarily on oper-
ative mortality in patients who underwent valve surgery.3,12
In these 2 studies crude mortality was 3- to 4-times higher
in patients undergoing valvular surgery compared with
values in those who underwent isolated CABG. One possible
explanation for the poorer outcome in these patients is a delay
in surgical intervention because of an underestimation of val-
vular heart disease.12 In patients with ESRD, typical presen-
tations of valvular heart disease caused by volume overload,
such as shortness of breath, effusions, and other symptoms of
congestive heart failure, can be concealed by dialysis, mak-
ing accurate diagnosis difficult.12,13 In addition, because of
known high operative risk, some of these patients might be
referred late for cardiac surgery with advanced valvular le-
sions, including extensive calcification and impaired left ven-
tricular function. While performing multivariate analysis in
the ESRD subgroup, we were able to identify PVD as a pre-
dictor of hospital mortality. Dialysis-dependent patients with
PVD were 2.5-times more likely to experience hospital mor-
tality compared with patients with ESRD without PVD. This
is probably a manifestation of the extent of atherosclerotic
disease in these patients affecting multiple organs. These
findings suggest that earlier detection of cardiac disease, as
well as other associated atherosclerotic diseases, might lead
to an earlier referral and potentially improve operative
outcome in this high-risk population.
Morbidity
A number of previous studies reported an association of
ESRD with major postoperative complications, such as
reoperation for bleeding and coagulation disorders, stroke, re-
spiratory failure,mediastinitis, and sepsis.9,12,14We identified
ESRD as an independent predictor of respiratory failure (OR,
2.0; 95%CI, 1.4–2.8; P, .001) and sepsis (OR, 2.7; 95%CI,
1.6–4.3;P, .001). Gastrointestinal complications showed an
association with ESRD in univariate analysis, but this associ-
ation disappeared in multivariate analysis. The increased risk920 The Journal of Thoracic and Cardiovascular Surgery c Aprfor perioperative infectious complications in patients with
ESRD might be explained by an immune-compromised state
caused by uremia, frequent dialysis, diabetes, or steroid ther-
apy for autoimmune causes of renal failure. However, despite
the increased risk of postoperative septic complications, we
did not observe a significant difference in the rate of mediasti-
nitis between patients undergoing dialysis and our general pa-
tient population. Thismight be explained by a large number of
patients who underwent valvular or aortic surgery in our
series, which usually carries a lower risk of postoperative
mediastinitis compared with that of CABG.15
In contrast to previous studies,9,16 we were not able to
show an association between ESRD and postoperative stroke
(3.3% in patients with ESRD vs 2.5% in the control group,
P5 .273). The risk of stroke in patients with dialysis under-
going cardiac surgery is related to the burden of atheroscle-
rotic disease, which predisposes patients with ESRD to
thrombembolic events and ischemic injury from low perfu-
sion pressure during CPB.16 Our finding of a relatively low
stroke rate (3.3%) in this patient population compared with
previous reports (6% to 7%) is probably related to the fact
that we routinely apply epiaortic scanning before manipula-
tion and cannulation of the ascending aorta in all patients,
use the axillary artery instead of the femoral artery as an in-
flow for arterial cannulation in patients undergoing complex
aortic surgery, and perform off-pump procedures in patients
undergoing CABG at risk.17 Another important adjunct is
that wemaintain high perfusion pressure (.70mmHg) during
CPB in all patients with PVD or patients older than 70 years.
In contrast to some previous studies, we did not observe an
association between ESRD and postoperative bleeding com-
plications. Previous studies have reported a rate of postoper-
ative bleeding in the range of 3% to 11% and associated this
event with platelet dysfunction and coagulation defects
caused by uremia and mechanical alterations of blood cells
during dialysis.18 Although this study was not designed to de-
termine the cause of reduced postoperative bleeding, the low
rate of bleeding complications might be explained by the use
of antifibrinolytic agents, such as 3-aminocaproic acid during
CPB. In addition, we currently perform a thromboelastogram
in these patients at the completion of CPB, with a low thresh-
old for the transfusion of platelets in patients with abnormal
findings and clinical signs of bleeding.
Long-term Survival
Few data exist with respect to long-term survival of patients
with ESRD after cardiac surgery. In their review of the liter-
ature, Frenken and Krian3 were able to identify 5 case series
with a total of 97 patients and reported a 5-year survival be-
tween 39% and 67%. In the subgroup of patients undergoing
valve procedures, the 5-year survival was only 39%. Franga
and coworkers,19 in their series of 44 patients, reported a
3-year and 5-year survival of 64% and 32%, respectively.
Finally, Jault and colleagues20 followed 99 patients whoil 2008
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served a survival of 47% at 6 years. In our series of 214 dis-
charged patients, we observed 1-year, 3-year, and
5-year survivals of 72.3% 6 3.3%, 53.3% 6 4.0%, and
39.0% 6 4.5% respectively. Late survival was not different
when patients were stratified by underlying procedure. The
importance of PVD and history of stroke for the outcome
of patients with ESRD after cardiac surgery has not previ-
ously been demonstrated. In our study previous stroke and
PVD were strong independent predictors of late mortality.
Three-year survival was 14.1% 6 7.2% and 32.8% 6
7.8% for patients with previous stroke and PVD, respec-
tively. These observations were confirmed when patients
were stratified by predicted mortality by using EuroSCORE.
These findings confirm that end-stage renal failure and asso-
ciated atherosclerotic disease negatively affect late outcome
after cardiac surgery. Therefore systematic preoperative
work-up for detection of coexisting atherosclerotic disease
is crucial to optimize patient selection to improve early and
late outcome of patients with ESRD undergoing cardiac
surgery.
Limitations
Despite the fact that all data were collected prospectively, this
is a retrospective observational study, and therefore any con-
clusions are limited in their application. This study analyzes
only patients with ESRD who were considered suitable by
referring nephrologists and cardiologists to undergo cardiac
operations. We do not have information about the number
of patients with ESRD and cardiovascular diseases requiring
surgical intervention who were considered to be too high risk
by their primary care physician to undergo an invasive surgi-
cal procedure during the same time period. Although we
report one of the largest series published in the literature,
the validation of independent predictors observed in our
study requires clinical series with greater numbers of patients
with ESRD undergoing cardiac surgery. Finally, clinical out-
come analysis focused on postoperative mortality and mor-
bidity, and we were not able to provide information on late
complications, quality of life, and cause of death after dis-
charge.
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CDAppendix 1. Variables included in this study
Variables
Age
Sex
Preoperative variables
Weight (kg)
Height (cm)
Body mass index (kg/m2)
Diabetes mellitus requiring medication
Hypertension
Prior cerebrovascular accident
Peripheral vascular disease
Chronic lung disease (chronic obstructive pulmonary disease)
Prior myocardial infarction
Prior heart operation
Congestive heart failure (New York Heart Association class III and IV)
Active endocarditis
Ejection fraction (%)
Urgent operation (requiring operation during current hospitalization)
Emergency operation (refractory unrelenting cardiac compromise requiring emergency operation)
Hemodynamic instability (patient requires pharmacologic or mechanical support to maintain blood pressure or output and acute
hypotension or low cardiac index despite support)
Preoperative intra-aortic balloon pump
Intraoperative variables
Type of procedure (isolated CABG, single/multiple valve, combined valve/CABG, aortic procedures)
Cardiopulmonary bypass time
Crossclamp time
Postoperative variables
Hospital mortality (death during same admission or within 30 d after surgical intervention when discharged)
Respiratory failure (prolonged ventilator therapy [.72 h], reintubation, or tracheostomy)
Stroke (new permanent neurological event)
Postoperative myocardial infarction
Bleeding requiring reoperation
Deep sternal wound infection
Unplanned reoperation
Gastrointestinal complication
Length of hospital stay
CABG, Coronary artery bypass grafting.922 The Journal of Thoracic and Cardiovascular Surgery c April 2008
